Curis (CRIS) Total Debt (2012 - 2025)

Curis (CRIS) reported Total Debt of $7.0 million for Q3 2025, down 5.47% quarter-over-quarter from $7.4 million in Q2 2025.

Curis (CRIS) Total Debt (2012 - 2025) Analysis & Trends

Curis has reported Total Debt for 12 years, with the latest figure at $7.0 million in Q3 2025.

For the quarter ending Q3 2025, Total Debt changed N/A year-over-year to $7.0 million; the trailing twelve-month figure through Sep 2025 stood at $7.0 million (changed N/A YoY), and the FY2024 full-year result was $7.6 million, down 11.15% from the prior year.
Total Debt for Q3 2025 stood at $7.0 million, down from $7.4 million in the prior quarter.
The five-year high for Total Debt was $8.5 million in Q4 2023, with the low at $891000.0 in Q1 2021.
Historically, Total Debt has averaged $6.4 million across 4 years, with a median of $7.3 million in 2025.
The largest YoY upside for Total Debt was 11.15% in 2024 against a maximum downside of 11.15% in 2024.
Curis' Total Debt stood at $891000.0 in 2021, then jumped by 854.43% to $8.5 million in 2023, then retreated by 11.15% to $7.6 million in 2024, then retreated by 8.01% to $7.0 million in 2025.
The last three Total Debt figures came in at $7.0 million (Q3 2025), $7.4 million (Q2 2025), and $7.2 million (Q1 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	319.10 Mn
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	-
9	Abivax	95.45 Bn	95.45 Bn	-	-
10	Curis	8.58 Mn	-6.42 Mn	-	-

Download Data